Myers Michael 4
4 · Quoin Pharmaceuticals, Ltd. · Filed Oct 30, 2023
Insider Transaction Report
Form 4
Myers Michael
DirectorChief Executive Officer
Transactions
- Award
Share Option (Right to Buy)
2023-10-26+80,965→ 80,965 totalExercise: $5.75From: 2024-10-26Exp: 2033-10-26→ American Depositary Share (80,965 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS.
- [F2]The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027.